UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 17, 2018

 

AMPHENOL CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Registrant’s telephone number, including area code (203) 265-8900

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

The annual meeting of stockholders of the Company was held on May 17, 2018.  As of March 19, 2018, the record date for the meeting, 302,001,190 shares of the Company’s Class A Common Stock were outstanding.  A quorum of 279,147,813 shares were present or represented at the meeting.

 

The stockholders (i) elected each of the Company’s nominees for director; (ii) ratified the selection of Deloitte & Touche LLP as independent accountants of the Company; (iii) approved the advisory vote on compensation of named executive officers;   and (iv) voted against a stockholder proposal for special shareholder meeting improvement. Voting of shares for each item, all of which are described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 13, 2018, is as follows:

 

1.              Election of Directors

 

		Votes For		Votes Against		Abstentions		Broker Non-votes
Ronald P. Badie		259,209,376		11,831,012		197,280		7,910,145
Stanley L. Clark		258,830,795		12,210,077		196,796		7,910,145
John D. Craig		269,726,082		1,350,234		161,352		7,910,145
David P. Falck		266,566,623		4,509,461		161,584		7,910,145
Edward G. Jepsen		258,581,816		12,477,619		178,233		7,910,145
Martin H. Loeffler		261,894,703		8,901,113		441,852		7,910,145
John R. Lord		257,454,407		13,585,883		197,378		7,910,145
R. Adam Norwitt		266,340,091		4,755,130		142,447		7,910,145
Diana G. Reardon		262,892,201		8,211,322		134,145		7,910,145
Anne Clarke Wolff		269,766,313		1,318,340		153,015		7,910,145

 

2.              Ratification of Selection of Deloitte & Touch LLP as Independent Accountants of the Company

 

Votes For:		272,881,996
Votes Against:		6,144,241
Abstentions:		121,576
Broker Non-Votes:		0

 

3.              Advisory Vote on Compensation of Named Executive Officers:

 

Votes For:		254,898,686
Votes Against:		16,107,500
Abstentions:		231,482
Broker Non-Votes:		7,910,145

 

4.              Stockholder Proposal for Special Shareholder Meeting Improvement:

 

Votes For:		99,608,524
Votes Against:		171,277,751
Abstentions:		351,393
Broker Non-Votes:		7,910,145

 

2

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

		AMPHENOL CORPORATION
	By:	/s/ R. Adam Norwitt
		R. Adam Norwitt
		President and Chief Executive Officer
Date: May 18, 2018

 

3